Albert Oriol
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 0.5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 257
- Multiple Myeloma Research and Treatments 227
- Oncology 173
- Peptidase Inhibition and Analysis 69
- Cancer Treatment and Pharmacology 40
- CAR-T cell therapy research 29
- Co-authors
- Josep‐María Ribera (55 shared papers)María‐Victoria Mateos (112 shared papers)Jesús F. San Miguel (82 shared papers)Evarist Feliú (31 shared papers)Joan Bladé (53 shared papers)Juan José Lahuerta (49 shared papers)Philippe Moreau (65 shared papers)Laura Rosiñol (55 shared papers)
- Journals
- Blood (82 papers)Journal of Clinical Oncology (42 papers)Haematologica (17 papers)HemaSphere (15 papers)British Journal of Haematology (10 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Albert Oriol
302 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Hematology 4.8k
- Oncology 3.1k
- Genetics 991
- Molecular Biology 3.2k
- Pathology and Forensic Medicine 775
Countries citing papers authored by Albert Oriol
This map shows the geographic impact of Albert Oriol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Oriol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Oriol more than expected).
Fields of papers citing papers by Albert Oriol
This network shows the impact of papers produced by Albert Oriol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Oriol. The network helps show where Albert Oriol may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Oriol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 313 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 818 |
| 2 | Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma Hit paper breakdown → | 2022 | 350 |
| 3 | 2013 | 348 | |
| 4 | 2017 | 281 | |
| 5 | 2010 | 202 | |
| 6 | 2008 | 184 | |
| 7 | 2011 | 157 | |
| 8 | 2002 | 138 | |
| 9 | 2009 | 128 | |
| 10 | Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. | 2005 | 110 |
| 11 | 2016 | 107 | |
| 12 | 2019 | 101 | |
| 13 | 2020 | 96 | |
| 14 | 2008 | 86 | |
| 15 | 2012 | 81 | |
| 16 | 2019 | 80 | |
| 17 | 2007 | 77 | |
| 18 | 2001 | 75 | |
| 19 | 2009 | 72 | |
| 20 | 2007 | 72 |
About Albert Oriol
Albert Oriol is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 313 papers that have together received 6.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (227 papers), Protein Degradation and Inhibitors (112 papers), Peptidase Inhibition and Analysis (69 papers), Chronic Lymphocytic Leukemia Research (43 papers), Cancer Treatment and Pharmacology (40 papers), CAR-T cell therapy research (29 papers), Acute Lymphoblastic Leukemia research (24 papers) and Lymphoma Diagnosis and Treatment (23 papers). The work is most often cited by research in Hematology (4.8k citations), Oncology (3.1k citations), Genetics (991 citations), Molecular Biology (3.2k citations) and Pathology and Forensic Medicine (775 citations). Albert Oriol has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Josep‐María Ribera, María‐Victoria Mateos, Jesús F. San Miguel, Evarist Feliú, Joan Bladé, Juan José Lahuerta, Philippe Moreau, Laura Rosiñol, Javier de la Rubia and Jesús María Hernández‐Rivas. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, HemaSphere and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.